7Baggers
 AN2 Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:46:41 GMT
 AN2 Therapeutics Narrows Losses And Pushes Ahead With Research  Finimize Wed, 12 Nov 2025 21:56:14 GMT
 AN2 Therapeutics reports Q3 EPS (31c), two estimates (22c)  TipRanks Wed, 12 Nov 2025 21:52:37 GMT
 AN2 Therapeutics Q3 net loss narrows to $9.4 mln  MarketScreener Wed, 12 Nov 2025 21:25:41 GMT
 Deal Watch: GSK To Tap AN2’s Boron Chemistry Approach In Tuberculosis R&D  Citeline News & Insights Wed, 12 Nov 2025 21:13:25 GMT
 AN2 Therapeutics partners with GSK to develop TB treatments  Investing.com Mon, 10 Nov 2025 12:09:42 GMT
 Prior Stephen David, AN2 Therapeutics chief strategy officer, sells $872 in stock  Investing.com Canada Fri, 07 Nov 2025 00:52:26 GMT
 Eizen Joshua M of AN2 Therapeutics sells $3213 in stock  Investing.com India Fri, 07 Nov 2025 00:28:22 GMT
 eizen joshua m of an2 therapeutics sells $3213 in stock by investing.com  Investing.com UK Thu, 06 Nov 2025 23:40:00 GMT
 AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit  simplywall.st Tue, 28 Oct 2025 07:00:00 GMT
 AN2 Therapeutics Advances with Phase 1 Trial of Oral AN2-502998  TipRanks Mon, 27 Oct 2025 07:00:00 GMT
 published on: 2025-10-19 00:32:14  nchmf.gov.vn Sat, 18 Oct 2025 17:32:14 GMT
 published on: 2025-10-18 22:13:43  Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 15:13:43 GMT
 [form 4] an2 therapeutics, inc. insider trading activity  Stock Titan Tue, 14 Oct 2025 20:01:06 GMT
 antx form 4: director awarded 10,367 shares; immediate vesting  Stock Titan Tue, 14 Oct 2025 20:01:04 GMT
 an2 therapeutics director receives 3,274-share grant; total 13,255  Stock Titan Tue, 14 Oct 2025 20:01:03 GMT

AN2 Therapeutics
(NASDAQ:ANTX) 

ANTX stock logo

Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.

Founded: 2017
IPO Price: $15 (Mar 25, 2022)
CEO: Eric E. Easom  
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends